Literature DB >> 33527080

Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection.

Ram Kothandan1, Cashlin Anna Suveetha Gnana Rajan1, Janamitra Arjun1, Rejoe Raymond Michael Raj1, Sowfia Syed1.   

Abstract

BACKGROUND: The present pandemic situation due to coronavirus has led to the search for newer prevention, diagnostic, and treatment methods. The onset of the corona infection in a human results in acute respiratory illness followed by death if not diagnosed and treated with suitable antiretroviral drugs. With the unavailability of the targeted drug treatment, several repurposed drugs are being used for treatment. However, the side-effects of the drugs urges us to move to a search for newer synthetic- or phytochemical-based drugs. The present study investigates the use of various phytochemicals virtually screened from various plant sources in Western Ghats, India, and subsequently molecular docking studies were performed to identify the efficacy of the drug in retroviral infection particularly coronavirus infection.
RESULTS: Out of 57 phytochemicals screened initially based on the structural and physicochemical properties, 39 were effectively used for the docking analysis. Finally, 5 lead compounds with highest hydrophobic interaction and number of H-bonds were screened. Results from the interaction analysis suggest Piperolactam A to be pocketed well with good hydrophobic interaction with the residues in the binding region R1. ADME and toxicity profiling also reveals Piperolactam A with higher LogS values indicating higher permeation and hydrophilicity. Toxicity profiling suggests that the 5 screened compounds to be relatively safe.
CONCLUSION: The in silico methods used in this study suggests that the compound Piperolactam A to be the most effective inhibitor of S-protein from binding to the GRP78 receptor. By blocking the binding of the S-protein to the CS-GRP78 cell surface receptor, they can inhibit the binding of the virus to the host. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43088-021-00095-x.
© The Author(s) 2021.

Entities:  

Keywords:  In silico drug design; Retroviral infection; Virtual screening

Year:  2021        PMID: 33527080      PMCID: PMC7841026          DOI: 10.1186/s43088-021-00095-x

Source DB:  PubMed          Journal:  Beni Suef Univ J Basic Appl Sci        ISSN: 2314-8535


  41 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 2.  Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.

Authors:  Sara Naghipour; Mahsa Ghodousi; Sara Rahsepar; Sepideh Elyasi
Journal:  Expert Rev Anti Infect Ther       Date:  2020-07-13       Impact factor: 5.091

3.  Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19.

Authors:  Nisha Muralidharan; R Sakthivel; D Velmurugan; M Michael Gromiha
Journal:  J Biomol Struct Dyn       Date:  2020-04-16

Review 4.  Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting.

Authors:  Min Ni; Yi Zhang; Amy S Lee
Journal:  Biochem J       Date:  2011-03-01       Impact factor: 3.857

Review 5.  Mechanisms of coronavirus cell entry mediated by the viral spike protein.

Authors:  Sandrine Belouzard; Jean K Millet; Beth N Licitra; Gary R Whittaker
Journal:  Viruses       Date:  2012-06-20       Impact factor: 5.048

6.  Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site.

Authors:  Umesh Kalathiya; Monikaben Padariya; Marcos Mayordomo; Małgorzata Lisowska; Judith Nicholson; Ashita Singh; Maciej Baginski; Robin Fahraeus; Neil Carragher; Kathryn Ball; Juergen Haas; Alison Daniels; Ted R Hupp; Javier Antonio Alfaro
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

7.  Indian traditional ayurvedic system of medicine and nutritional supplementation.

Authors:  M M Pandey; Subha Rastogi; A K S Rawat
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-23       Impact factor: 2.629

8.  Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants.

Authors:  Muhammad Tahir Ul Qamar; Safar M Alqahtani; Mubarak A Alamri; Ling-Ling Chen
Journal:  J Pharm Anal       Date:  2020-03-26

Review 9.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.

Authors:  Indwiani Astuti
Journal:  Diabetes Metab Syndr       Date:  2020-04-18

10.  The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection.

Authors:  Dat P Ha; Richard Van Krieken; Anthony J Carlos; Amy S Lee
Journal:  J Infect       Date:  2020-06-12       Impact factor: 6.072

View more
  1 in total

Review 1.  Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19.

Authors:  Rajeshwari Singh; Sumeet Goel; Pascale Bourgeade; Lotfi Aleya; Devesh Tewari
Journal:  Environ Sci Pollut Res Int       Date:  2021-09-07       Impact factor: 5.190

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.